Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Viemed Healthcare ( (VMD) ) has provided an announcement.
On June 5, 2025, Viemed Healthcare, Inc. held its Annual General and Special Meeting of Shareholders, where several key decisions were made. Shareholders approved an amendment to the 2024 Long Term Incentive Plan, which increases the number of shares available, clarifies vesting in the event of a change in control, and sets a minimum one-year vesting period. Additionally, all seven director nominees were elected, Ernst & Young LLP was appointed as the independent auditor, and the executive compensation package was approved. The frequency of future advisory votes on executive compensation was also set to occur annually.
The most recent analyst rating on (VMD) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Viemed Healthcare stock, see the VMD Stock Forecast page.
Spark’s Take on VMD Stock
According to Spark, TipRanks’ AI Analyst, VMD is a Neutral.
Viemed Healthcare shows robust financial growth and strategic expansion efforts, reflected in its solid earnings call performance. However, technical indicators suggest caution due to potential short-term pressures. The company’s valuation is reasonable given its growth outlook, although improvement in free cash flow management remains crucial.
To see Spark’s full report on VMD stock, click here.
More about Viemed Healthcare
Average Trading Volume: 150,515
Technical Sentiment Signal: Sell
Current Market Cap: $268.4M
For detailed information about VMD stock, go to TipRanks’ Stock Analysis page.